Serum Fibrosis Marker Levels Decrease After Successful Antiviral Treatment in Chronic Hepatitis C Patients with Advanced Fibrosis

Por Fontana, Robert J., Bonkovsky, Herbert L., Naishadham, Deepa, Dienstag, Jules L., Sterling, Richard K., Lok, Anna SF, Su, Grace L.
Publicado em 2008

Iron Levels in Hepatocytes and Portal Tract Cells Predict Progression and Outcome of Patients with Advanced Chronic Hepatitis C

Por Lambrecht, Richard W., Sterling, Richard K., Naishadham, Deepa, Stoddard, Anne M., Rogers, Thomas, Morishima, Chihiro, Morgan, Timothy R., Bonkovsky, Herbert L.
Publicado em 2011

Predicting US and State-Level Cancer Counts for the Current Calendar Year: Part I – Evaluation of Temporal Projection Methods for Mortality

Por Chen, Huann-Sheng, Portier, Kenneth, Ghosh, Kaushik, Naishadham, Deepa, Kim, Hyune-Ju, Zhu, Li, Pickle, Linda W., Krapcho, Martin, Scoppa, Steve, Jemal, Ahmedin, Feuer, Eric J.
Publicado em 2012

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C

Por Fontana, Robert J., Dienstag, Jules L., Bonkovsky, Herbert L., Sterling, Richard K., Naishadham, Deepa, Goodman, Zachary D., Lok, Anna S. F., Wright, Elizabeth C., Su, Grace L.
Publicado em 2010

Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C

Por Fontana, Robert J., Sanyal, Arun J., Ghany, Marc G., Bonkovsky, Herbert L., Morgan, Timothy R., Litman, Heather J., Reid, Andrea E., Lee, William M., Naishadham, Deepa
Publicado em 2010

Issues in Design and Implementation in an Urban Birth Cohort Study: The Syracuse AUDIT Project

Por Crawford, Judith A., Hargrave, Teresa M., Hunt, Andrew, Liu, Chien-Chih, Anbar, Ran D., Hall, Geralyn E., Naishadham, Deepa, Czerwinski, Maria H., Webster, Noah, Lane, Sandra D., Abraham, Jerrold L.
Publicado em 2006

REDUCTION IN HEPATIC INFLAMMATION IS ASSOCIATED WITH LESS FIBROSIS PROGRESSION AND FEWER CLINICAL OUTCOMES IN ADVANCED HEPATITIS C

Por Morishima, Chihiro, Shiffman, Mitchell L., Dienstag, Jules L., Lindsay, Karen L, Szabo, Gyongyi, Everson, Gregory T., Lok, Anna S., Di Bisceglie, Adrian M., Ghany, Marc G., Naishadham, Deepa, Morgan, Timothy R., Wright, Elizabeth C.
Publicado em 2012

DNA polymorphisms and response to treatment in patients with chronic hepatitis C: Results from the HALT-C trial

Por Morgan, Timothy R., Lambrecht, Richard W., Bonkovsky, Herbert L., Chung, Raymond T., Naishadham, Deepa, Sterling, Richard K., Fontana, Robert J., Lee, William M., Ghany, Marc G., Wright, Elizabeth C., O’Brien, Thomas R.
Publicado em 2008

Factors that Determine the Development and Progression of Gastroesophageal Varices in Patients with Chronic Hepatitis C

Por Fontana, Robert J., Sanyal, Arun J., Ghany, Marc G., Lee, William M., Reid, Andrea E., Naishadham, Deepa, Everson, Gregory T., Kahn, Jeffrey A., Di Bisceglie, Adrian M., Szabo, Gyongyi, Morgan, Timothy R., Everhart, James E.
Publicado em 2010

EFFECT OF HCV RNA SUPPRESSION DURING PEGINTERFERON ALFA-2A MAINTENANCE THERAPY ON CLINICAL OUTCOMES IN THE HALT-C TRIAL

Por Shiffman, Mitchell L, Morishima, Chihiro, Dienstag, Jules L, Lindsay, Karen L, Hoefs, John C, Lee, William M, Wright, Elizabeth C., Naishadham, Deepa, Everson, Gregory T, Lok, Anna S, Di Bisceglie, Adrian M, Bonkovsky, Herbert L, Ghany, Marc G
Publicado em 2009

Variants in Interferon-α Pathway Genes and Response to Pegylated-Interferon-α2a plus Ribavirin for Treatment of Chronic HCV Infection in the HALT-C Trial

Por Welzel, Tania Mara, Morgan, Timothy R., Bonkovsky, Herbert L., Naishadham, Deepa, Pfeiffer, Ruth M., Wright, Elizabeth C., Hutchinson, Amy A., Crenshaw, Andrew T., Bashirova, Arman, Carrington, Mary, Dotrang, Myhanh, Sterling, Richard K., Lindsay, Karen L., Fontana, Robert J., Lee, William M., Di Bisceglie, Adrian M., Ghany, Marc G., Gretch, David R., Chanock, Stephen J., Chung, Raymond T., O’Brien, Thomas R.
Publicado em 2009